ATH434 (formerly PBT434), which recently completed a Phase 2 clinical trial for multiple system atrophy (MSA), acts as an orally available iron chaperone that redistributes labile iron in preclinical models of MSA and PD (Pall et al., 2024
Incredibly sophisticated in how it works, but incredibly simple in how its delivered, this peptide represents the future of medicineespecially when it comes to recovery
The supplement is manufactured in a GMP-certified facility and is quality evaluated for purity and potency
Our data showed that hyperlipidemia-induced transsulfuration impairment blocked the homocysteine conversion to cysteine, which led to not only upstream accumulation of homocysteine, but also downstream deficiency of cysteine and subsequent reduction of antioxidant GSH synthesis
The goal is straightforward: present what the company states, highlight what can be independently observed, and flag what prospective patients should verify before enrolling
Water retention or mild edema